×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: APOE Lipid Dysregulation Causal Chain in AD
mechanism
1,560 words
KG: ent-gene-e685040a
2026-04-01
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
APOE Lipid Dysregulation Causal Chain in AD
🔬
Protein Info
Gene Symbol
ent-gene-e685040a
Chromosome
19q13.32
Associated Diseases
Alzheimer's_disease
KG Connections
5
knowledge graph edges
Databases
GeneCards
UniProt
NCBI Gene
HPA
STRING
Knowledge Graph
Related Hypotheses (30)
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
APOE4-Specific Microglial Metabolic Rescue
Score: 0.50
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid
Score: 0.49
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in
Score: 0.46
Astrocyte Metabolic Reprogramming via APOE4 Correction
Score: 0.45
APOE4-Lipid Metabolism Correction
Score: 0.43
Membrane Cholesterol Gradient Modulators
Score: 0.52
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56
Ganglioside Rebalancing Therapy
Score: 0.50
APOE-TREM2 Interaction Modulation
Score: 0.48
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.47
Sphingolipid Metabolism Reprogramming
Score: 0.44
Flotillin-1 Stabilization Compounds
Score: 0.42
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Conversion Therapy
Score: 0.44
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Show 25 more
Related Analyses (30)
Lipid metabolism dysregulation and membrane integrity in Alz
neurodegeneration · completed
Mechanistic role of APOE in neurodegeneration
neurodegeneration · completed
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (30)
KEEPS Continuation: Long-term effects of menopausal hormone
clinical · proposed · Score: 0.95
GWAS of composite biomarker score
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75
GWAS of plasma NfL in East Asian cohort
exploratory · proposed · Score: 0.95
GWAS of plasma pTau217 in East Asian cohort
exploratory · proposed · Score: 0.95
Dairy intake and dementia risk in Malmö Diet and Cancer coho
clinical · proposed · Score: 0.95
Real-world safety study of Lecanemab in Japanese AD patients
clinical · proposed · Score: 0.95
GWAS of plasma pTau181 in East Asian cohort
exploratory · proposed · Score: 0.95
GWAS of plasma GFAP in East Asian cohort
exploratory · proposed · Score: 0.95
DDT/DDE exposure and cognitive function in Latina women
clinical · proposed · Score: 0.90
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.46
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.46
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.46
Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.46
Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.46
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.46
Cholinergic System Dysfunction in DLB — Mechanisms and Thera
clinical · proposed · Score: 0.46
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.46
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.46
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.46
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.46
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.46
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.46
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.46
Show 25 more
See Also (3)
Endolysosomal Pathway in Alzheimer's Disease
mechanism · Pages share 3 hypotheses
APOE4 and Alzheimer's Disease Risk
mechanism · Pages share 3 hypotheses
APOE Lipid Metabolism Pathway in Alzheimer's Disease
mechanism · Pages share 3 hypotheses
Knowledge Graph (5 edges)
ent-gene-e685040a
data_in
ad_genetic_risk_loci:APOE
ent-gene-e685040a
data_in
benchmark_ot_ad_answer_key:APOE
ent-gene-e685040a
associated_with
Alzheimer's_disease
ad_genetic_risk_loci:APOE
data_in
ent-gene-e685040a
benchmark_ot_ad_answer_key:APOE
data_in
ent-gene-e685040a